In the past decade, a growing body of literature has reported promising results for prostate-
specific membrane antigen (PSMA)-targeted radionuclide imaging and therapy in prostate …

Prostate-specific membrane antigen (PSMA) is a promising target for imaging diagnostics
and targeted radionuclide therapy (theranostics) of prostate cancer and its metastases …

Prostate-specific membrane antigen (PSMA) is a type II transmembrane glycoprotein that is
highly overexpressed on prostate cancer epithelial cells and for which there is a growing …

The high incidence rates of prostate cancer (PCa) raise demand for improved therapeutic
strategies. Prostate tumors specifically express the prostate‐specific membrane antigen …

Background Prostate-specific membrane antigen (PSMA) is the up-and-coming target for
molecular imaging of prostate cancer. Despite its name, non-prostate-related PSMA …

Purpose We developed a theranostic radiopharmaceutical that engages two key cell surface
proteases, fibroblast activation protein alpha (FAP) and prostate-specific membrane antigen …

In the past decades, the expanding use of prostate-specific membrane antigen (PSMA)
imaging for prostate cancer has led to the incidental detection of a lot of extra-prostatic …

Background Renal masses detection is continually increasing worldwide, with Renal Cell
Carcinoma (RCC) accounting for approximately 90% of all renal cancers and remaining one …

Purpose To evaluate parameters derived from 68 Ga-PSMA-11 PET/CT images for
discriminating pathological characteristics in primary clear-cell renal cell carcinoma …

Background Prostate-specific membrane antigen (PSMA) is overexpressed in the
neovasculature of renal cell carcinoma (RCC). However, there remains limited evidence …